These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1848929)

  • 21. Potentiation of nitrogen mustard cytotoxicity by disulfiram, diethyldithiocarbamic acid, and diethylamine in mice.
    Valeriote F; Grates HE
    Cancer Res; 1989 Dec; 49(23):6658-61. PubMed ID: 2555050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of buthionine sulfoximine on the lethality of ifosfamide and ifosfamide-induced urotoxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):455-8. PubMed ID: 2727395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between prevention of cataract development by disulfiram and fates of selenium in selenite-treated rats.
    Ito Y; Cai H; Koizumi Y; Nakao M; Terao M
    Curr Eye Res; 1999 Apr; 18(4):292-9. PubMed ID: 10372989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promising antitumour drug disulfiram inhibits viability and induces apoptosis in cardiomyocytes.
    Li Y; Shen J; Fang M; Huang X; Yan H; Jin Y; Li J; Li X
    Biomed Pharmacother; 2018 Dec; 108():1062-1069. PubMed ID: 30372806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
    Li C; Zhou S; Chen C; Zhu L; Li S; Song Z; Liang J; Tang C; Xu N; Liu T; Liu S
    Colloids Surf B Biointerfaces; 2023 May; 225():113253. PubMed ID: 36934611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of ifosfamide toxicity using dose fractionation.
    Rodriguez V; Bodey GP; Freireich EJ; McCredie KB; McKelvey EM; Tashima CK
    Cancer Res; 1976 Aug; 36(8):2945-8. PubMed ID: 1277203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide.
    Veverka KA; Johnson KL; Mays DC; Lipsky JJ; Naylor S
    Biochem Pharmacol; 1997 Feb; 53(4):511-8. PubMed ID: 9105402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diethyldithiocarbamate methyl ester sulfoxide, an inhibitor of rat liver mitochondrial low Km aldehyde dehydrogenase and putative metabolite of disulfiram.
    Madan A; Faiman MD
    Alcohol Clin Exp Res; 1994 Aug; 18(4):1013-7. PubMed ID: 7978080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of disulfiram on the carcinogenicity of nitrosamines.
    Schweinsberg F; Weissenberger I; Burkle V
    IARC Sci Publ; 1982; (41):649-57. PubMed ID: 7141572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of disulfiram on mixed function oxidase system and trace element concentration in the liver of rats.
    Bertram B; Schuhmacher J; Frei E; Frank N; Wiessler M
    Biochem Pharmacol; 1982 Nov; 31(22):3613-9. PubMed ID: 7181942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of cyclophosphamide and ifosfamide pharmacology.
    Fleming RA
    Pharmacotherapy; 1997; 17(5 Pt 2):146S-154S. PubMed ID: 9322882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis.
    Bellmunt J; Eres N; Ribas A; Casado S; Albanell J; Baselga J
    Cancer Chemother Pharmacol; 1997; 40(3):273-6. PubMed ID: 9219513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism for the potentiation of oxygen toxicity by disulfiram.
    Forman HJ; York JL; Fisher AB
    J Pharmacol Exp Ther; 1980 Mar; 212(3):452-5. PubMed ID: 6244385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of mixed disulfides from disulfiram on the metabolism and genotoxicity of N-nitrosodiethylamine.
    Lee BH; Bertram B; Rajca A; Frank N; Schmezer P; Wiessler M
    Arzneimittelforschung; 1995 Sep; 45(9):1024-8. PubMed ID: 7488305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of disulfiram on cyclophosphamide-mediated myeloid toxicity.
    Gamelli RL; Ershler WB; Hacker MP; Foster RS
    Cancer Chemother Pharmacol; 1986; 16(2):153-5. PubMed ID: 3948301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target Inhibition of IL-1 Receptor Prevents Ifosfamide Induced Hemorrhagic Cystitis in Mice.
    Leite CA; Alencar VT; Melo DL; Mota JM; Melo PH; Mourão LT; Wong DV; Magalhães PJ; Santos AA; Brito GA; Lima-Júnior RC; Cunha FQ; Ribeiro RA
    J Urol; 2015 Dec; 194(6):1777-86. PubMed ID: 26220217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.
    Cormier JN; Patel SR; Herzog CE; Ballo MT; Burgess MA; Feig BW; Hunt KK; Raney RB; Zagars GK; Benjamin RS; Pisters PW
    Cancer; 2001 Sep; 92(6):1550-5. PubMed ID: 11745234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of diethyldithiocarbamate methyl ester sulfine as an intermediate in the bioactivation of disulfiram.
    Madan A; Faiman MD
    J Pharmacol Exp Ther; 1995 Feb; 272(2):775-80. PubMed ID: 7853193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines.
    Cohen JD; Robins HI
    Invest New Drugs; 1990 May; 8(2):137-42. PubMed ID: 2166719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of disulfiram on the metabolism of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Irving CC; Daniel DS
    Carcinogenesis; 1987 Sep; 8(9):1309-15. PubMed ID: 3113755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.